TP53 and cancer: We further observed that hepatic activation of FOXO3 enhanced liver inflammation (Fig. 2a) and led to an elevation of cancer-associated genes, such as Trp53 (P < 0.05) and Myc (P < 0.01) (Fig. 2b).